Genetic profiling of circulating cell‐free DNA from cerebrospinal fluid and paired plasma in ALK‐positive lung cancer with brain metastases
Abstract Background This study used next‐generation sequencing (NGS) to investigate the genetic profiles in cerebrospinal fluid (CSF), plasma, and tumor tissue to explore alternative detection methods for anaplastic lymphoma kinase (ALK) rearrangement status and potential resistance mechanisms to AL...
Main Authors: | Liang Shi, Lili Guo, Hong Tao, Qiyi Meng, Li Tong, Junfang Tang, Kun Li, Shucai Zhang, Zhe Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-07-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14936 |
Similar Items
-
Treatment of Patients with ALK-positive Non-small Cell Lung Cancer
and Brain Metastases
by: Jialin LV, et al.
Published: (2016-08-01) -
Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution
by: Hainan Yang, et al.
Published: (2022-12-01) -
Sequential ALK inhibitor treatment benefits patient with leptomeningeal metastasis harboring non‐EML4‐ALK rearrangements detected from cerebrospinal fluid: A case report
by: Zhaona Li, et al.
Published: (2020-01-01) -
Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single‐cell transcriptome analysis
by: Haoyu Ruan, et al.
Published: (2020-12-01) -
Prediction of trough concentration and ALK occupancy in plasma and cerebrospinal fluid using physiologically based pharmacokinetic modeling of crizotinib, alectinib, and lorlatinib
by: Bole Li, et al.
Published: (2023-11-01)